America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Kemin Industries launches sciORIAN™, a cloud-based platform for rendering operations, offering real-time monitoring, AI-driven insights, and top-notch security.